Bird Rock Bio. Inc.

3:30 PM - 3:45 PM (EDT), Tuesday, October 22, 2019 ・ 2nd Floor
Bird Rock Bio is a clinical stage biopharmaceutical company focused on developing innovative immuno-inflammatory regulators. Backed by leading biotechnology venture investors, our strategy leverages biologic targets with substantial human proof of mechanism for the development of novel, best-in-class therapeutic antibodies with significant clinical and commercial differentiation.
Company Type:
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2006
Main Therapeutic Focus:
Lead Product in Development:
nimacimab
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
1
Speaker
photo
President and CEO
Bird Rock Bio Inc.